1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Tuberculosis Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Radiographic Method 1.2.3 Diagnostic Laboratory Methods 1.2.4 Nucleic Acid Testing 1.2.5 Phage Assay 1.2.6 Detection of Latent Infection 1.2.7 Cytokine Detection Assay 1.2.8 Detection of Drug Resistance 1.3 Market by Application 1.3.1 Global Tuberculosis Diagnostic Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Infants 1.3.3 Adults 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Tuberculosis Diagnostic Market Perspective (2016-2027) 2.2 Tuberculosis Diagnostic Growth Trends by Regions 2.2.1 Tuberculosis Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Tuberculosis Diagnostic Historic Market Share by Regions (2016-2021) 2.2.3 Tuberculosis Diagnostic Forecasted Market Size by Regions (2022-2027) 2.3 Tuberculosis Diagnostic Industry Dynamic 2.3.1 Tuberculosis Diagnostic Market Trends 2.3.2 Tuberculosis Diagnostic Market Drivers 2.3.3 Tuberculosis Diagnostic Market Challenges 2.3.4 Tuberculosis Diagnostic Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Tuberculosis Diagnostic Players by Revenue 3.1.1 Global Top Tuberculosis Diagnostic Players by Revenue (2016-2021) 3.1.2 Global Tuberculosis Diagnostic Revenue Market Share by Players (2016-2021) 3.2 Global Tuberculosis Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Tuberculosis Diagnostic Revenue 3.4 Global Tuberculosis Diagnostic Market Concentration Ratio 3.4.1 Global Tuberculosis Diagnostic Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Diagnostic Revenue in 2020 3.5 Tuberculosis Diagnostic Key Players Head office and Area Served 3.6 Key Players Tuberculosis Diagnostic Product Solution and Service 3.7 Date of Enter into Tuberculosis Diagnostic Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Tuberculosis Diagnostic Breakdown Data by Type 4.1 Global Tuberculosis Diagnostic Historic Market Size by Type (2016-2021) 4.2 Global Tuberculosis Diagnostic Forecasted Market Size by Type (2022-2027) 5 Tuberculosis Diagnostic Breakdown Data by Application 5.1 Global Tuberculosis Diagnostic Historic Market Size by Application (2016-2021) 5.2 Global Tuberculosis Diagnostic Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Tuberculosis Diagnostic Market Size (2016-2027) 6.2 North America Tuberculosis Diagnostic Market Size by Type 6.2.1 North America Tuberculosis Diagnostic Market Size by Type (2016-2021) 6.2.2 North America Tuberculosis Diagnostic Market Size by Type (2022-2027) 6.2.3 North America Tuberculosis Diagnostic Market Size by Type (2016-2027) 6.3 North America Tuberculosis Diagnostic Market Size by Application 6.3.1 North America Tuberculosis Diagnostic Market Size by Application (2016-2021) 6.3.2 North America Tuberculosis Diagnostic Market Size by Application (2022-2027) 6.3.3 North America Tuberculosis Diagnostic Market Size by Application (2016-2027) 6.4 North America Tuberculosis Diagnostic Market Size by Country 6.4.1 North America Tuberculosis Diagnostic Market Size by Country (2016-2021) 6.4.2 North America Tuberculosis Diagnostic Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Tuberculosis Diagnostic Market Size (2016-2027) 7.2 Europe Tuberculosis Diagnostic Market Size by Type 7.2.1 Europe Tuberculosis Diagnostic Market Size by Type (2016-2021) 7.2.2 Europe Tuberculosis Diagnostic Market Size by Type (2022-2027) 7.2.3 Europe Tuberculosis Diagnostic Market Size by Type (2016-2027) 7.3 Europe Tuberculosis Diagnostic Market Size by Application 7.3.1 Europe Tuberculosis Diagnostic Market Size by Application (2016-2021) 7.3.2 Europe Tuberculosis Diagnostic Market Size by Application (2022-2027) 7.3.3 Europe Tuberculosis Diagnostic Market Size by Application (2016-2027) 7.4 Europe Tuberculosis Diagnostic Market Size by Country 7.4.1 Europe Tuberculosis Diagnostic Market Size by Country (2016-2021) 7.4.2 Europe Tuberculosis Diagnostic Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Tuberculosis Diagnostic Market Size (2016-2027) 8.2 Asia-Pacific Tuberculosis Diagnostic Market Size by Type 8.2.1 Asia-Pacific Tuberculosis Diagnostic Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Tuberculosis Diagnostic Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Tuberculosis Diagnostic Market Size by Type (2016-2027) 8.3 Asia-Pacific Tuberculosis Diagnostic Market Size by Application 8.3.1 Asia-Pacific Tuberculosis Diagnostic Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Tuberculosis Diagnostic Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Tuberculosis Diagnostic Market Size by Application (2016-2027) 8.4 Asia-Pacific Tuberculosis Diagnostic Market Size by Region 8.4.1 Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Tuberculosis Diagnostic Market Size (2016-2027) 9.2 Latin America Tuberculosis Diagnostic Market Size by Type 9.2.1 Latin America Tuberculosis Diagnostic Market Size by Type (2016-2021) 9.2.2 Latin America Tuberculosis Diagnostic Market Size by Type (2022-2027) 9.2.3 Latin America Tuberculosis Diagnostic Market Size by Type (2016-2027) 9.3 Latin America Tuberculosis Diagnostic Market Size by Application 9.3.1 Latin America Tuberculosis Diagnostic Market Size by Application (2016-2021) 9.3.2 Latin America Tuberculosis Diagnostic Market Size by Application (2022-2027) 9.3.3 Latin America Tuberculosis Diagnostic Market Size by Application (2016-2027) 9.4 Latin America Tuberculosis Diagnostic Market Size by Country 9.4.1 Latin America Tuberculosis Diagnostic Market Size by Country (2016-2021) 9.4.2 Latin America Tuberculosis Diagnostic Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Tuberculosis Diagnostic Market Size (2016-2027) 10.2 Middle East & Africa Tuberculosis Diagnostic Market Size by Type 10.2.1 Middle East & Africa Tuberculosis Diagnostic Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Tuberculosis Diagnostic Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Tuberculosis Diagnostic Market Size by Type (2016-2027) 10.3 Middle East & Africa Tuberculosis Diagnostic Market Size by Application 10.3.1 Middle East & Africa Tuberculosis Diagnostic Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Tuberculosis Diagnostic Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Tuberculosis Diagnostic Market Size by Application (2016-2027) 10.4 Middle East & Africa Tuberculosis Diagnostic Market Size by Country 10.4.1 Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Thermo Fisher Scientific 11.1.1 Thermo Fisher Scientific Company Details 11.1.2 Thermo Fisher Scientific Business Overview 11.1.3 Thermo Fisher Scientific Tuberculosis Diagnostic Introduction 11.1.4 Thermo Fisher Scientific Revenue in Tuberculosis Diagnostic Business (2016-2021) 11.1.5 Thermo Fisher Scientific Recent Development 11.2 Hologic Corporation 11.2.1 Hologic Corporation Company Details 11.2.2 Hologic Corporation Business Overview 11.2.3 Hologic Corporation Tuberculosis Diagnostic Introduction 11.2.4 Hologic Corporation Revenue in Tuberculosis Diagnostic Business (2016-2021) 11.2.5 Hologic Corporation Recent Development 11.3 Abbott 11.3.1 Abbott Company Details 11.3.2 Abbott Business Overview 11.3.3 Abbott Tuberculosis Diagnostic Introduction 11.3.4 Abbott Revenue in Tuberculosis Diagnostic Business (2016-2021) 11.3.5 Abbott Recent Development 11.4 Becton Dickinson 11.4.1 Becton Dickinson Company Details 11.4.2 Becton Dickinson Business Overview 11.4.3 Becton Dickinson Tuberculosis Diagnostic Introduction 11.4.4 Becton Dickinson Revenue in Tuberculosis Diagnostic Business (2016-2021) 11.4.5 Becton Dickinson Recent Development 11.5 Roche 11.5.1 Roche Company Details 11.5.2 Roche Business Overview 11.5.3 Roche Tuberculosis Diagnostic Introduction 11.5.4 Roche Revenue in Tuberculosis Diagnostic Business (2016-2021) 11.5.5 Roche Recent Development 11.6 bioMerieux 11.6.1 bioMerieux Company Details 11.6.2 bioMerieux Business Overview 11.6.3 bioMerieux Tuberculosis Diagnostic Introduction 11.6.4 bioMerieux Revenue in Tuberculosis Diagnostic Business (2016-2021) 11.6.5 bioMerieux Recent Development 11.7 Sanofi 11.7.1 Sanofi Company Details 11.7.2 Sanofi Business Overview 11.7.3 Sanofi Tuberculosis Diagnostic Introduction 11.7.4 Sanofi Revenue in Tuberculosis Diagnostic Business (2016-2021) 11.7.5 Sanofi Recent Development 11.8 Cepheid 11.8.1 Cepheid Company Details 11.8.2 Cepheid Business Overview 11.8.3 Cepheid Tuberculosis Diagnostic Introduction 11.8.4 Cepheid Revenue in Tuberculosis Diagnostic Business (2016-2021) 11.8.5 Cepheid Recent Development 11.9 Hain Lifescience 11.9.1 Hain Lifescience Company Details 11.9.2 Hain Lifescience Business Overview 11.9.3 Hain Lifescience Tuberculosis Diagnostic Introduction 11.9.4 Hain Lifescience Revenue in Tuberculosis Diagnostic Business (2016-2021) 11.9.5 Hain Lifescience Recent Development 11.10 QIAGEN 11.10.1 QIAGEN Company Details 11.10.2 QIAGEN Business Overview 11.10.3 QIAGEN Tuberculosis Diagnostic Introduction 11.10.4 QIAGEN Revenue in Tuberculosis Diagnostic Business (2016-2021) 11.10.5 QIAGEN Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Tuberculosis Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Radiographic Method Table 3. Key Players of Diagnostic Laboratory Methods Table 4. Key Players of Nucleic Acid Testing Table 5. Key Players of Phage Assay Table 6. Key Players of Detection of Latent Infection Table 7. Key Players of Cytokine Detection Assay Table 8. Key Players of Detection of Drug Resistance Table 9. Global Tuberculosis Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Tuberculosis Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Tuberculosis Diagnostic Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global Tuberculosis Diagnostic Market Share by Regions (2016-2021) Table 13. Global Tuberculosis Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global Tuberculosis Diagnostic Market Share by Regions (2022-2027) Table 15. Tuberculosis Diagnostic Market Trends Table 16. Tuberculosis Diagnostic Market Drivers Table 17. Tuberculosis Diagnostic Market Challenges Table 18. Tuberculosis Diagnostic Market Restraints Table 19. Global Tuberculosis Diagnostic Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Tuberculosis Diagnostic Market Share by Players (2016-2021) Table 21. Global Top Tuberculosis Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnostic as of 2020) Table 22. Ranking of Global Top Tuberculosis Diagnostic Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by Tuberculosis Diagnostic Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Tuberculosis Diagnostic Product Solution and Service Table 26. Date of Enter into Tuberculosis Diagnostic Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Tuberculosis Diagnostic Market Size by Type (2016-2021) (US$ Million) Table 29. Global Tuberculosis Diagnostic Revenue Market Share by Type (2016-2021) Table 30. Global Tuberculosis Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global Tuberculosis Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global Tuberculosis Diagnostic Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global Tuberculosis Diagnostic Revenue Market Share by Application (2016-2021) Table 34. Global Tuberculosis Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global Tuberculosis Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America Tuberculosis Diagnostic Market Size by Type (2016-2021) (US$ Million) Table 37. North America Tuberculosis Diagnostic Market Size by Type (2022-2027) & (US$ Million) Table 38. North America Tuberculosis Diagnostic Market Size by Application (2016-2021) (US$ Million) Table 39. North America Tuberculosis Diagnostic Market Size by Application (2022-2027) & (US$ Million) Table 40. North America Tuberculosis Diagnostic Market Size by Country (2016-2021) & (US$ Million) Table 41. North America Tuberculosis Diagnostic Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe Tuberculosis Diagnostic Market Size by Type (2016-2021) (US$ Million) Table 43. Europe Tuberculosis Diagnostic Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe Tuberculosis Diagnostic Market Size by Application (2016-2021) (US$ Million) Table 45. Europe Tuberculosis Diagnostic Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe Tuberculosis Diagnostic Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Tuberculosis Diagnostic Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Tuberculosis Diagnostic Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific Tuberculosis Diagnostic Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific Tuberculosis Diagnostic Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific Tuberculosis Diagnostic Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific Tuberculosis Diagnostic Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America Tuberculosis Diagnostic Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America Tuberculosis Diagnostic Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America Tuberculosis Diagnostic Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America Tuberculosis Diagnostic Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America Tuberculosis Diagnostic Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America Tuberculosis Diagnostic Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa Tuberculosis Diagnostic Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa Tuberculosis Diagnostic Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa Tuberculosis Diagnostic Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa Tuberculosis Diagnostic Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa Tuberculosis Diagnostic Market Size by Country (2022-2027) & (US$ Million) Table 66. Thermo Fisher Scientific Company Details Table 67. Thermo Fisher Scientific Business Overview Table 68. Thermo Fisher Scientific Tuberculosis Diagnostic Product Table 69. Thermo Fisher Scientific Revenue in Tuberculosis Diagnostic Business (2016-2021) & (US$ Million) Table 70. Thermo Fisher Scientific Recent Development Table 71. Hologic Corporation Company Details Table 72. Hologic Corporation Business Overview Table 73. Hologic Corporation Tuberculosis Diagnostic Product Table 74. Hologic Corporation Revenue in Tuberculosis Diagnostic Business (2016-2021) & (US$ Million) Table 75. Hologic Corporation Recent Development Table 76. Abbott Company Details Table 77. Abbott Business Overview Table 78. Abbott Tuberculosis Diagnostic Product Table 79. Abbott Revenue in Tuberculosis Diagnostic Business (2016-2021) & (US$ Million) Table 80. Abbott Recent Development Table 81. Becton Dickinson Company Details Table 82. Becton Dickinson Business Overview Table 83. Becton Dickinson Tuberculosis Diagnostic Product Table 84. Becton Dickinson Revenue in Tuberculosis Diagnostic Business (2016-2021) & (US$ Million) Table 85. Becton Dickinson Recent Development Table 86. Roche Company Details Table 87. Roche Business Overview Table 88. Roche Tuberculosis Diagnostic Product Table 89. Roche Revenue in Tuberculosis Diagnostic Business (2016-2021) & (US$ Million) Table 90. Roche Recent Development Table 91. bioMerieux Company Details Table 92. bioMerieux Business Overview Table 93. bioMerieux Tuberculosis Diagnostic Product Table 94. bioMerieux Revenue in Tuberculosis Diagnostic Business (2016-2021) & (US$ Million) Table 95. bioMerieux Recent Development Table 96. Sanofi Company Details Table 97. Sanofi Business Overview Table 98. Sanofi Tuberculosis Diagnostic Product Table 99. Sanofi Revenue in Tuberculosis Diagnostic Business (2016-2021) & (US$ Million) Table 100. Sanofi Recent Development Table 101. Cepheid Company Details Table 102. Cepheid Business Overview Table 103. Cepheid Revenue in Tuberculosis Diagnostic Business (2016-2021) & (US$ Million) Table 104. Cepheid Recent Development Table 105. Hain Lifescience Company Details Table 106. Hain Lifescience Business Overview Table 107. Hain Lifescience Tuberculosis Diagnostic Product Table 108. Hain Lifescience Revenue in Tuberculosis Diagnostic Business (2016-2021) & (US$ Million) Table 109. Hain Lifescience Recent Development Table 110. QIAGEN Company Details Table 111. QIAGEN Business Overview Table 112. QIAGEN Tuberculosis Diagnostic Product Table 113. QIAGEN Revenue in Tuberculosis Diagnostic Business (2016-2021) & (US$ Million) Table 114. QIAGEN Recent Development Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Global Tuberculosis Diagnostic Market Share by Type: 2020 VS 2027 Figure 2. Radiographic Method Features Figure 3. Diagnostic Laboratory Methods Features Figure 4. Nucleic Acid Testing Features Figure 5. Phage Assay Features Figure 6. Detection of Latent Infection Features Figure 7. Cytokine Detection Assay Features Figure 8. Detection of Drug Resistance Features Figure 9. Global Tuberculosis Diagnostic Market Share by Application: 2020 VS 2027 Figure 10. Infants Case Studies Figure 11. Adults Case Studies Figure 12. Tuberculosis Diagnostic Report Years Considered Figure 13. Global Tuberculosis Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Tuberculosis Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Tuberculosis Diagnostic Market Share by Regions: 2020 VS 2027 Figure 16. Global Tuberculosis Diagnostic Market Share by Regions (2022-2027) Figure 17. Global Tuberculosis Diagnostic Market Share by Players in 2020 Figure 18. Global Top Tuberculosis Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Diagnostic as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Tuberculosis Diagnostic Revenue in 2020 Figure 20. Global Tuberculosis Diagnostic Revenue Market Share by Type (2016-2021) Figure 21. Global Tuberculosis Diagnostic Revenue Market Share by Type (2022-2027) Figure 22. North America Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Tuberculosis Diagnostic Market Share by Type (2016-2027) Figure 24. North America Tuberculosis Diagnostic Market Share by Application (2016-2027) Figure 25. North America Tuberculosis Diagnostic Market Share by Country (2016-2027) Figure 26. United States Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Tuberculosis Diagnostic Market Share by Type (2016-2027) Figure 30. Europe Tuberculosis Diagnostic Market Share by Application (2016-2027) Figure 31. Europe Tuberculosis Diagnostic Market Share by Country (2016-2027) Figure 32. Germany Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Tuberculosis Diagnostic Market Share by Type (2016-2027) Figure 40. Asia-Pacific Tuberculosis Diagnostic Market Share by Application (2016-2027) Figure 41. Asia-Pacific Tuberculosis Diagnostic Market Share by Region (2016-2027) Figure 42. China Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Tuberculosis Diagnostic Market Share by Type (2016-2027) Figure 50. Latin America Tuberculosis Diagnostic Market Share by Application (2016-2027) Figure 51. Latin America Tuberculosis Diagnostic Market Share by Country (2016-2027) Figure 52. Mexico Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Tuberculosis Diagnostic Market Share by Type (2016-2027) Figure 56. Middle East & Africa Tuberculosis Diagnostic Market Share by Application (2016-2027) Figure 57. Middle East & Africa Tuberculosis Diagnostic Market Share by Country (2016-2027) Figure 58. Turkey Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Tuberculosis Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis Diagnostic Business (2016-2021) Figure 62. Hologic Corporation Revenue Growth Rate in Tuberculosis Diagnostic Business (2016-2021) Figure 63. Abbott Revenue Growth Rate in Tuberculosis Diagnostic Business (2016-2021) Figure 64. Becton Dickinson Revenue Growth Rate in Tuberculosis Diagnostic Business (2016-2021) Figure 65. Roche Revenue Growth Rate in Tuberculosis Diagnostic Business (2016-2021) Figure 66. bioMerieux Revenue Growth Rate in Tuberculosis Diagnostic Business (2016-2021) Figure 67. Sanofi Revenue Growth Rate in Tuberculosis Diagnostic Business (2016-2021) Figure 68. Cepheid Revenue Growth Rate in Tuberculosis Diagnostic Business (2016-2021) Figure 69. Hain Lifescience Revenue Growth Rate in Tuberculosis Diagnostic Business (2016-2021) Figure 70. QIAGEN Revenue Growth Rate in Tuberculosis Diagnostic Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

Thermo Fisher Scientific Hologic Corporation Abbott Becton Dickinson Roche bioMerieux Sanofi Cepheid Hain Lifescience QIAGEN